Filing Flows › Evolus (EOLS) › Q3 2026 › vs Q3 2025
Evolus (EOLS) Q3 2026 vs Q3 2025 (year over year)
Evolus's revenue rose $9.0M (+13%) from $69.0M in Q3 2025 to $78.0M in Q3 2026. The biggest changes: Product revenue, net +$8.2M (+12%); Service revenue +$741K (—).
Evolus, Q3 2026: revenue $78.0M (+13% year over year), operating margin -10.8%, net loss $12.5M, operating cash flow −$1.9M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Product revenue, net | $77.2M | $69.0M | $8.2M | +12% |
| Service revenue | $741K | $0 | $741K | — |
| Revenue | $78.0M | $69.0M | $9.0M | +13% |
| Net loss | $12.5M | $15.7M | −$3.2M | -20% |
| Costs & expenses | $90.5M | $84.7M | $5.8M | +7% |
| Operating costs | $86.4M | $80.5M | $5.9M | +7% |
| Interest & other, net | $3.8M | $4.1M | −$267K | -7% |
| Income tax | $285K | $167K | $118K | +71% |
| Cost of revenue | $27.3M | $23.1M | $4.1M | +18% |
| Research & development | $2.0M | $2.0M | −$78K | -4% |
| SG&A | $52.9M | $52.8M | $107K | +0.2% |
| Other operating costs | $4.2M | $2.5M | $1.7M | +70% |
| Operating cash sources | $12.5M | $15.7M | −$3.2M | -20% |
| Depreciation & amortization | $2.4M | $2.0M | $433K | +22% |
| Share-based compensation | $5.6M | $5.1M | $468K | +9% |
| Working capital & other | $2.6M | −$6.0M | $8.6M | — |
| Cash used in operations | $1.9M | $14.7M | −$12.7M | -87% |
| Net loss absorbed | $12.5M | $15.7M | −$3.2M | -20% |
Questions
How much did Evolus's revenue grow year over year in Q3 2026?
Evolus's revenue rose $9.0M (+13%) from $69.0M in Q3 2025 to $78.0M in Q3 2026.
What drove Evolus's revenue change in Q3 2026?
Product revenue, net +$8.2M (+12%); Service revenue +$741K (—).